SNDX-5613 manufacturers
- SNDX-5613
-
- $1.00 / 150box
-
2022-11-21
- CAS:2169919-21-3
- Min. Order: 1box
- Purity: 98%
- Supply Ability: 1
|
| SNDX-5613 Basic information |
Product Name: | SNDX-5613 | Synonyms: | SNDX-5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-;SNDX-5613 SNDX5613;Revumenib;N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide | CAS: | 2169919-21-3 | MF: | C32H47FN6O4S | MW: | 630.82 | EINECS: | | Product Categories: | | Mol File: | 2169919-21-3.mol | |
| SNDX-5613 Chemical Properties |
Boiling point | 739.1±70.0 °C(Predicted) | density | 1.28±0.1 g/cm3(Predicted) | solubility | DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM) | pka | 11.10±0.40(Predicted) | form | Solid | color | White to off-white |
| SNDX-5613 Usage And Synthesis |
| SNDX-5613 Preparation Products And Raw materials |
|